Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -2.16
- Piotroski Score 4.00
- Grade N/A
- Symbol (YS)
- Company YS Biopharma Co., Ltd.
- Price $1.02
- Changes Percentage (9.68%)
- Change $0.09
- Day Low $0.90
- Day High $1.10
- Year High $1.78
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/20/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.56
- Trailing P/E Ratio -1.82
- Forward P/E Ratio -1.82
- P/E Growth -1.82
- Net Income $-145,479,105
Income Statement
Quarterly
Annual
Latest News of YS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
If the Jets don't want Aaron Rodgers back, the 4-time MVP will find another home: Analysis
The New York Jets face uncertainty with Joe Douglas gone and Aaron Rodgers potentially leaving. Rodgers' contract situation poses challenges for the Jets. Potential destinations for Rodgers include th...
By AP NEWS | 14 hours ago -
Cara Delevingne Says She Took Taylor Swift on a 'Wild Ride' When They Lived Together: 'She's Very Homely'
Cara Delevingne reflects on living with Taylor Swift after a breakup, praising Swift's caring nature and humor. The friends have supported each other for years, attending events and shows together. De...
By PEOPLE.com | 14 hours ago -
EU Chips Act 2.0 should include legacy chips, says industry group chief
The European Commission plans to enhance its computer chip sector, including foundational and legacy semiconductors. The European Chips Act aims to boost Europe's chip market share to 20% by 2030....
By Yahoo! Finance | 15 hours ago
